Search
for

    Sort by

    Research 361–390 of 410

    1. UTILIDADES DE LA ESPIRONOLACTONA COMO FÁRMACO ANTIANDROGÉNICO La Ciencia al Servicio de la Salud y Nutrición · 2024
    2. DHEA : why, when, and how much ? D’après la conférence de Bruno Allolio (Wuerzburg), 50e Journées internationales d’endocrinologie clinique Henri-Pierre KLOTZ, septembre 2007 Annales D Endocrinologie · 2009
    3. Improved Efficacy of Low-Dose Spironolactone and Metformin Combination Than Either Drug Alone in the Management of Women With Polycystic Ovary Syndrome (PCOS): A Six-Month, Open-Label Randomized Study The Journal of Clinical Endocrinology and Metabolism · 2013 · 75 citations
    4. Association of metabolic syndrome with female pattern hair loss in women: A case-control study International Journal of Dermatology · 2016 · 21 citations
    5. Clinical Case Seminar: Postmenopausal androgen excess-challenges in diagnostic work-up and management of ovarian thecosis Clinical Endocrinology · 2017 · 20 citations
    6. Determining the normal cut-off levels for hyperandrogenemia in Chinese women of reproductive age European Journal of Obstetrics & Gynecology and Reproductive Biology · 2010 · 16 citations
    7. Gynecologic and andrologic dermatology and the metabolic syndrome Clinics in Dermatology · 2017 · 14 citations
    8. Endocrinopathies and Other Disorders Inducing a Polycystic Ovary Syndrome Phenotype S. Karger AG eBooks · 2012 · 7 citations
    9. Effective treatment of skin and metabolic manifestations of hyperandrogenism: a comprehensive improvement of quality of life Медицинский совет · 2019 · 2 citations
    10. Clinicopathologic and Morphologic Analysis of the Adrenal Gland in Pomeranians with Non-Illness Alopecia The Japanese Journal of Veterinary Dermatology · 2005 · 2 citations
    11. Efficacy and safety of systemic spironolactone for acne in female patients in Sulaymaniyah teaching center of dermatology Advanced medical journal · 2024
    12. Spironolactone Elsevier eBooks · 2015
    13. Post-finasteride syndrome Anais Brasileiros De Dermatologia · 2020 · 15 citations
    14. Cardiometabolic risk factors in women with non-classic congenital adrenal hyperplasia Acta Cardiologica · 2019 · 2 citations
    15. Trilostane Treatment of Canine Alopecia X in an American Pit Bull Terrier Acta Veterinaria Brno · 2007
    16. SINDROMA CUSHING PADA KEHAMILAN INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY · 2018 · 2 citations
    17. Dermatologia e Procedimentos Estéticos Ed. XXVII Editora Pasteur eBooks · 2025
    18. Spironolactone treatment for dermatologic indications is not associated with hypotension in a single-center retrospective study Journal of the American Academy of Dermatology · 2024 · 4 citations
    19. Bilateral adrenalectomy induces early onset of summer fur growth in mink (Mustela vison) 1995 · 5 citations
    20. Association of Hypertension and Serum Aldosterone Levels in Male Patients with Androgenetic Alopecia: A Case-Control Study Journal of Multidisciplinary Healthcare · 2026
    21. Remission in Cushing disease with cabergoline 2008 · 5 citations
    22. Advanced Diagnostic Approaches and Current Medical Management of Insulinomas and Adrenocortical Disease in Ferrets (Mustela putorius furo) ˜The œveterinary clinics of North America. Exotic animal practice · 2010 · 44 citations
    23. The significance of CYP11A1 expression in skin physiology and pathology Molecular and Cellular Endocrinology · 2021 · 91 citations
    24. The Utility of Monitoring Potassium in Transgender, Gender Diverse, and Nonbinary Individuals on Spironolactone Journal of the Endocrine Society · 2022 · 11 citations
    25. Spironolactone versus Bicalutamide for Female Pattern Hair Loss: A 24-Month Unicenter Retrospective Comparative Study of Effectiveness and Safety Dermatology and Therapy · 2026
    26. Cardiovascular risk in patients with scarring and nonscarring alopecias: Assessing the current state of evidence JEADV Clinical Practice · 2023
    27. COVID-19 and androgenic status: testosterone or dihydrotestosterone have a pivotal role? Journal of men's health · 2023
    28. Comorbidities in patients with androgenetic alopecia: cardiovascular risk factors and benign prostatic hyperplasia 2011
    29. Simultaneous pharmacokinetic and pharmacodynamic analysis of 5α-reductase inhibitors and androgens by liquid chromatography tandem mass spectrometry Talanta · 2014 · 20 citations
    30. Effectiveness of short term canrenone treatment in idiopathic hirsutism. PubMed · 1989 · 2 citations